News
Dr. Dongxiao Zhang joins Analytical Biosciences as Chief Executive Officer of the U.S. Company
On May 1, 2022, Analytical Biosciences is pleased to announce that Dr. Dongxiao (Tony) Zhang, a veteran of the life sciences and pharmaceutical industry, joins as Chief Executive Officer of Abiosciences Inc., who will lead company’s single cell genomics partnership and services, sales and marketing, and corporate development.
Go to
Dr. Su Zhang Joins Analytical BioSciences as Vice President of Global Strategy and Business Development
March 1, 2022, Analytical BioSciences (Abio) is pleased to announce that Dr. Su Zhang, a life sciences and pharmaceutical industry veteran, joins Abio as Vice President, Global Head of BD and Strategy. She will lead the pharmaceutical and biotechnology business partnerships and strategic development for the company.
Go to
Dr. Xiaodong Andy Huang is promoted as the Chief Scientific Officer (CSO) of Analytical BioSciences
Dr. Xiaodong Andy Huang, Senior Vice President of Analytical BioSciences (Abio), is promoted to Chief Scientific Officer (CSO) to lead the company's overall drug R&D work, also will lead the Shanghai Discovery and Development Center to continuously improve the company's drug R&D capabilities and further accelerate the development of our innovative drug pipeline and discovery platforms.
Go to
[Publication] Journal of Experimental Medicine | Single-cell immune profiling reveals functional diversity of T cells in tuberculous pleural effusion
Jan 21th, 2022, Beijing - Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, is pleased to share that our client, Prof. Xinchun Chen’s group in Shenzhen University School of Medicine, has published a paper about tuberculous pleural effusion (TPE) in Journal of Experimental Medicine. Abio made great contributions to the single-cell data analysis part of the study.
Go to
Analytical BioSciences Releases OmniBrowser™ v3.1: A Powerful Data Exploration Platform with the Largest Multi-omics Single-cell Datasets Collection in the World
On December 21, 2021, Analytical BioSciences, a single-cell genomics and discovery company, released OmniBrowser™ v3.1, a new version of OmniBrowser™, providing more data and tools for single-cell data visualization and analysis to further empower innovative drug discovery and development.
Go to
Science | Pan-Cancer Single Cell Landscape of Tumor-Infiltrating T Cells
On December 17, 2021, the research group led by Prof. Zemin Zhang, a researcher at Biomedical Pioneering Innovation Center (BIOPIC), School of Life Sciences, and Beijing Advanced Innovation Center for Genomics (ICG) of Peking University, the founder of Analytical BioSciences, published an article on Science, revealed pan-cancer single cell landscape of tumor-infiltrating T cells.
Go to
Abiosciences has got the certification for Visium Spatial Solutions from 10x Genomics
We are happy to announce that Abiosciences, our branch in CA has got the certification for Visium Spatial Solutions from 10x Genomics.
Go to
Single-cell analyses reveal key immune cell subsets associated with response to PD-L1 blockade in triple-negative breast cancer
Oct 14th, 2021, Beijing - Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, is pleased to share that our client, Prof. Zhihua Liu’s group in Cancer Hospital of Chinese Academy of Medical Sciences, in close collaborations with Prof. Zemin Zhang’s group in Biomedical Pioneering Innovation Center of Peking University, has published a paper today about triple-negative breast cancer (TNBC) in Cancer Cell, a well-known academic journal in cancer research. Abio made great contributions to the single-cell sequencing experimental part of the study.
Go to
Professor Zemin Zhang wins the Natural Science First Prize of Beijing Science and Technology Award (2020)
On September 25, Beijing Science and Technology Award（2020）was publicly announced. Professor Zemin Zhang, a researcher at Biomedical Pioneering Innovation Center (BIOPIC) and Beijing Advanced Innovation Center for Genomics (ICG) of Peking University, the founder of Analytical BioSciences (Abio), won the first prize of the Natural Science Award for the project "Single Cell Atlas of Tumor Infiltrating T Cells".
Go to
The Shanghai R&D Center of Analytical BioSciences Officially Launched
On September 26th, 2021, Analytical BioSciences (Abio), a leader in single cell genomics, held the opening ceremony of its Shanghai R&D Center. Prof. Zemin Zhang, founder and scientific advisor of Abio, Mr. Tao Hong, co-founder and chief operation officer of Abio, Dr. Xiaodong Andy Huang, Senior Vice President of Abio, official leader of Xuhui District, representatives of investors including IDG Capital, Sequoia Capital China and SoftBank China
Go to
Analytical Biosciences Named Finalist in IDC’s Inaugural Best in Future of Digital Infrastructure North America Awards
Analytical Biosciences and MemVerge implement world’s first Big Memory Computing environment for genomics research to fight cancer and stop the spread of COVID-19
Go to
New Product | OmniAnalyzer®, A One-stop Single-Cell Data Analysis Software
On September 2nd, 2021, Analytical BioSciences releases a one-stop single-cell data analysis software, OmniAnalyzer®. OmniAnalyzer® is a standalone software for single cell multi-omics data analysis on code-free interface, enabling interactive data visualizations and generating publishable results.
Go to
Analytical BioScience Reached Commercial Agreement with Human Cell Atlas
We are happy to announce that we have reached a commercial agreement with the Human Cell Atlas (HCA) to help empower science discoveries of HCA collaborating members by providing #SingleCell sequencing and data analysis solutions, software and platform at a favorable price.
Go to
Analytical BioSciences Closes Series A4 Financing Led by Sequoia Capital China to Accelerate Single-cell Genomics & AI Based Cancer Therapeutics and Diagnostics
May 25 2021, Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, today announced the successful completion of Series A4 financing. Sequoia Capital China led this round of investment, and was joined by Green Pine Capital Partners and Primavera Venture Partners. IDG Capital, the original founding investor for Analytical Biosciences, also participated in this financing round.
Go to
Dr. Xiaodong Andy Huang Joins Analytical BioSciences as SVP
On May 1st, drug discovery expert and cancer biologist, Dr. Xiaodong Andy Huang joins Analytical BioSciences as senior vice president, leading the drug development of the company.
Go to
Professor Zemin Zhang and Professor Fuchou Tang are selected in 2020 Highly Cited Chinese Researchers list
Recently, Elsevier released the 2020 Highly Cited Chinese Researchers list. Professor Zemin Zhang and Professor Fuchou Tang of Peking University, both scientific advisors of Analytical BioSciences, were selected in the list.
Go to
Professor Zemin Zhang and Professor Fuchou Tang are selected as World's Top 2% Scientists 2020
Recently, Stanford University released a list of World's Top 2% Scientists 2020. Among them, Professor Zemin Zhang and Professor Fuchou Tang of Peking University, both scientific advisors of Analytical BioSciences, was selected as the "Annual Impact" list of the top 2% of the world's top scientists in 2020.
Go to
Professor Zemin Zhang' s Research Group and Analytical BioSciences Developed A Novel Methods for Multiple Single-Cell Datasets Integration
Feb 18, 2021 Beijing - Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, is please to share that its founder and scientific advisor, Professor Zemin Zhang of Peking University, has published a papers on Genome Biology titled “iMAP: integration of multiple single-cell datasets by adversarial paired transfer networks”，This seminal work is a collaborative effort between Zhang Lab at Peking University and Analytical BioSciences.
Go to
Analytical BioSciences, BioMap Partner in Strategic Development of Single Cell Big Data and AI/analytical Platform
February 9, 2021 Beijing – Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, announced today of an investment from and a strategic joint effort with BioMap, a AI-powered Life Sciences Company initiated and founded by Baidu’s founder Robin Li, to develop commercial analytical platforms and big data infrastructure for applications of single cell genomics in biomedical fields and develop a single-cell + AI innovation ecosystem.
Go to
Research Using Single Cell Genomics Continue to Advance Scientific Understanding of Cancer and COVID-19 Diseases
Feb 2021 Beijing - Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, is pleased to share that its founder and scientific advisor，Professor Zemin Zhang of Peking University, has published three seminal papers this week on Covid-19 and Cancer Immunology.
Go to
Professor Zemin Zhang' s Research Group and Collaborators Reveal the Features of Tumor Infiltrating Myeloid Cells By Pan-Cancer Single-Cell Transcriptional Atlas
Feb 4, 2021 Beijing - Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, is please to share that its founder and scientific advisor, Professor Zemin Zhang of Peking University, has published a papers on Cell titled “A Pan-Cancer Single-Cell Transcriptional Atlas of Tumor Infiltrating Myeloid Cells”.
Go to
COVID-19 immune features revealed by a large-scale single cell transcriptome atlas, initiated by the Single Cell Consortium for COVID-19 in China, Analytical BioSciences is involved In
Feb 3, 2021 Beijing - Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, is please to share that its founder and scientific advisor, Professor Zemin Zhang of Peking University, has published a paper on Covid-19.
Go to
Professor Zemin Zhang' s Research Group and Collaborators Analyze the Heterogeneity and the Complex Network of Tumor Microenvironment of Nasopharyngeal Carcinoma
Feb 2, 2021 Beijing - Analytical BioSciences Ltd. (Abio), a leader in single cell genomics, is please to share that its founder and scientific advisor, Professor Zemin Zhang of Peking University, has published a papers on Nature Communications titled “Tumour Heterogeneity and Intercellular Networks of Nasopharyngeal Carcinoma at Single Cell Resolution”.
Go to
Analytical BioSciences Launches OmniBrowser™: A Powerful Data Exploration Platform with the Largest scRNA-seq Datasets Collection in the World
On January 4, 2021, Analytical BioSciences, a single-cell genomics and discovery company, launched OmniBrowserTM, a comprehensively curated single cell data compendium with visualization and analysis capabilities that further empower innovative drug discovery and development.
Go to
Analytical BioSciences Closes Series A+ Financing Led by SoftBank China to Accelerate Single-cell Genomics Based Cancer Therapeutics and Diagnostics
In Oct 2020, Analytical BioSciences and 10x Genomics reach cooperation in single-cell sequencing analysis, Analytical BioSciences becomes a validated partner in CPP（Compatible Partner Program）of 10x Genomics. Since then, Analytical BioSciences will provide cutting-edge single-cell sequencing data analysis for 10x Genomics and its client.
Go to
Analytical BioSciences cooperate with 10x Genomics in single-cell sequencing analysis
In Oct 2020, Analytical BioSciences and 10x Genomics reach cooperation in single-cell sequencing analysis, Analytical BioSciences becomes a validated partner in CPP（Compatible Partner Program）of 10x Genomics. Since then, Analytical BioSciences will provide cutting-edge single-cell sequencing data analysis for 10x Genomics and its client.
Go to
Research group led by FuChou Tang publishes an article on Cancer Cell, revealed prevalent genomic alterations in tumor stromal cells of human colorectal cancer
On October 22, 2020, the scientific advisor of Analytical Biosciences, Prof. FuChou Tang and his research group published an article on Cancer Cell, titled with “Single-Cell Multiomics Sequencing Reveals Prevalent Genomic Alterations in Tumor Stromal Cells of Human Colorectal Cancer”, together with Wei Fu’s group, provides evidence and functional relevance of pervasive genomic alterations in the stromal cells of tumor microenvironment in Colorectal Cancer.
Go to
Analytical BioSciences and Professor Zemin Zhang's research group developed a new tool for evaluating the purity of single cell group——ROGUE
On June 22th, Analytical BioSciences and Professor Zemin Zhang's research group published a bioinformatics methodology paper on Nature Communications, titled " An entropy-based metric for assessing the purity of single cell populations ", officially released ROGUE, a new tool for unsupervised gene selection and cell group purity assessment based on single-cell transcriptome data.
Go to
Professor Zemin Zhang's group develope a new computational tool CSOmap to reconstruct cell spatial organization
On June 15, 2020, the founder and scientific adviser of Analytical Biosciences，Professor Zemin Zhang and his group published a paper on Cell Research, title with "Reconstruction of cell spatial organization from single-cell RNA sequencing data based on ligand-receptor". The paper present a new algorithm for cell spatial relationships based on cell interaction, CSOmap.
Go to
Professor Zemin Zhang's group publishes an article on Cell，revealing the mechanism of immunotherapy of colorectal cancer targeting myeloid cells
On April 16, the founder and scientific adviser of Analytical BioSciences, Professor Zemin Zhang and his research group published an article on Cell with collaborators，titled "Single-Cell Analyses Inform Mechanisms of Myeloid-Targeted Therapies In Colon Cancer", which systematically characterized the tumor microenvironment of patients with colorectal cancer by using single-cell transcriptome sequencing，especially the infiltrating myeloid cell group for the first time. Meanwhile, it uses a mouse model to explain the potential mechanism of immunotherapeutic strategies of anti-CD40 agonists and anti-CSF1R inhibitor targeting myeloid cells.
Go to
Analytical BioSciences and Professor Zemin Zhang's research group developed a new tool for single-cell transcriptome rapid annotation——SciBet
On April 14th, Analytical BioSciences and Professor Zemin Zhang's research group published a bioinformatics methodology paper on Nature Communications, titled "SciBet as a portable and fast single cell type identifier ", officially released SciBet, a new tool for fast and supervised cell type annotation based on single-cell transcriptome data.
Go to
Dr. Yuelan Wang joins Abiosciences as Vice President
April 17, 2020: Dr. Yuelan Wang joined Abiosciences as the Vice President, leading the research and development of the company's bioinformatics software department.
Go to
Analytical Biosciences forms Domestic Sequencing Platform Ecological Application Alliance with 7 partners, promotes the development of gene industry
On March 16th, 2020, 8 companies, including Analytical BioSciences, MGI, Geneplus, iGeneTech, WeGene, NextOmics, TSINGKE, IGENECODE, form the Domestic Sequencing Platform Application Ecological Alliance. By the alliance, members will provide the more competitive products and services to customers in various segments of the industry by cooperation, creating a new ecology for the Chinese gene industry.
Go to
Research of Professor Zemin Zhang group recognized in Top Ten Advances in Bioinformatics of China 2019
The research group of Professor Zemin Zhang, the founder and scientific consultant of Analytical Biosciences, has made a pioneering breakthrough of hepatocellular carcinoma. On February 16, 2020, the research was recognized in Top Ten Advances in Bioinformatics of China 2019 recognized by the peer reviewers organized by Genomics, Proteomics and Bioinformatics (GPB) journal.
Go to
Prof.Zemin Zhang interviewed by Hanhai BioTalk
On Feb 23, 2020, the founder of Analytical Biosciences, Professor Zemin Zhang, was invited to attend the Hanhai BioTalk series of lectures, and was interviewed by Dr. Zhang Jian, the chief scientist of Hanhai, talking about "single cell research and application of disease tissue".
Go to
Research group led by Prof. FuChou Tang publishes cover article on Cell，reveals aging mechanism of primate ovarian
On January 30, 2020, the scientific advisor of Analytical Biosciences, Prof. FuChou Tang and his research group published a cover article on Cell entitled “Single-Cell Transcriptomic Atlas of Primate Ovarian Aging”, together with Guanghui Liu’s group and other collaborative teams, revealed the aging mechanism of primate ovarian.
Go to
Zemin Zhang 's group and collaborators make great progress in tumor transcriptome alterations
On February 5, the founder and scientific advisor of Analytical Biosciences, Professor Zemin Zhang and his research group published a paper on Nature entitled "Genomic basis for RNA alterations in cancer" ，together with Alvis Brazma, Angela Brooks, Gunnar Rätsch and other collaborating teams. The research paper reports major advances in the field of tumor transcriptome alteration.
Go to
Nature Cancer invites Professor Zemin Zhang to envision the next breakthroughs in cancer
Recently, a new subsidiary journal of Nature, Nature Cancer was officially launched. It invited 10 leading scientists who approach cancer from diverse perspectives to ask them about the key developments in their fields and what their envision will be the next breakthroughs in cancer and published the first issue “A roadmap for the next decade in cancer research”.
Go to
1st anniversary of Analytical Biosciences: investment from IDG, cooperation with Bayer, Pfizer and other well-known pharmaceutical companies
On December 17, 2019, Analytical Biosciences celebrates its first birthday.
Go to
Analytical BioSciences has been certified by 10x Genomics: leading single-cell sequencing and analysis to the future
On October 24, 2019, Analytical BioSciences Limited received the official notification of 10x Genomics, and was approved as a 10x Genomics Certified Service Provider for the Chromium Single Cell Immune Profiling Solution. Analytical BioSciences also obtained the official certification from 10x Genomics for the Single Cell 5' gene expression and VDJ analysis. This was the first time that 10x Genomics certified this technology to an institution in China. Therefore, Analytical BioSciences becomes the only domestic institution that has been certified by 10x Genomics for single cell immune profiling.
Go to
Prof. Fushen Tang and Prof. Zemin Zhang introduce the progress of single cell research at the Single Cell Omics Beijing 2019 Symposium
From October 20th to 21st,the ‘Single Cell Omics Beijing 2019 Symposium’ co-sponsored by Beijing Advanced Innovation Center for Genomics (ICG) and Biomedical Pioneering Innovation Center (BIOPIC), was held in Qiulin lecture hall of Peking University. Analytical Biosciences participated in the symposium as a major sponsor, attracting many teachers and students and promoted heated discussions by its single cell sequencing and analysis technology.
Go to
Runsheng Chen and Fuchou Tang appointed to the Scientific Advisor Board of Analytical Biosciences
On June 17, the appointment ceremony of scientific advisors of Analytical Biosciences took place in the Beijing office. Analytical Biosciences invited Professor Runsheng Chen from Institute of Biophysics of the Chinese Academy of Sciences, Professor Fuchou Tang from Peking University, and Professor Zemin Zhang from Peking University to join its Scientific Advisory Board. The goal of these appointment is to advance the research and technology capacities and to enhance the impact of single-cell sequencing and bioinformatics.
Go to
Runsheng Chen and Zemin Zhang presented the progress of precision medicine and single-cell cancer studies at the 5th precision medicine and gene sequencing conference
On June 29, 2019, the fifth precision medicine and gene sequencing conference was held in the academic hall of Peking Union Medical College. The conference was co-sponsored by seqChina, Peking Union Medical College Hospital and Beijing Medical Award Foundation. Prof. Runsheng Chen and Prof. Zemin Zhang were invited to attend the conference and presented the plenary lectures, which received extensive attention, discussion and recognition from the participants.
Go to
Boxi Kang presented E-test and Scibet at the Cold Spring Harbor Conference in Asia
On the June 10, Mr. Boxi Kang, head of the Bioinformatics Department of Analytical Biosciences, gave a lecture entitled “A Framework for Real-time Analysis and Visualization of Large Single-cell RNA-seq Data” on the Cold Spring Harbor Asia Conference (Suzhou) on the Scientific and Technical Advances in Cancer Immunology.
Go to
© Analytical Biosciences Limited. All rights reserved.